Zobrazeno 1 - 10
of 64
pro vyhledávání: '"M M Fort"'
Publikováno v:
The Journal of Immunology. 144:3341-3346
The propensity of HIV-1 to undergo sequence variation, particularly in the envelope glycoprotein gp120, complicates vaccine development and may enable the virus to evade ongoing immune responses in infected individuals. We present here a molecular an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d91769379083c0732a91f54610e91bc
https://doi.org/10.4049/jimmunol.144.9.3341
https://doi.org/10.4049/jimmunol.144.9.3341
Autor:
D M, Rennick, M M, Fort
Publikováno v:
American journal of physiology. Gastrointestinal and liver physiology. 278(6)
Interleukin (IL)-10(-/-) mice spontaneously develop intestinal inflammation characterized by discontinuous transmural lesions affecting the small and large intestine and by dysregulated production of proinflammatory cytokines. The uncontrolled genera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3c07209e98c2c1edbdb1a4899049372a
https://pubmed.ncbi.nlm.nih.gov/10859210
https://pubmed.ncbi.nlm.nih.gov/10859210
Autor:
M, Guiguet, F, Barbut, J L, Meynard, F, Raynaud, M M, Fort, M, Chandon, F, Isnard, J, Frottier, G, Offenstadt
Publikováno v:
Presse medicale (Paris, France : 1983). 28(25)
Risk factors for infectious complications of central venous catheters (CVC) were compared between CVC used for short and long periods to identify patients at risk.A prospective study was conducted over a 6 month period in two general intensive care u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c24f315694db88d2fd40676b27b9eaa2
https://pubmed.ncbi.nlm.nih.gov/10506861
https://pubmed.ncbi.nlm.nih.gov/10506861
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 161(7)
Previous studies have shown that the chronic inflammation observed in the colon of IL-10-deficient (IL-10(-/-)) mice is mediated by CD4+ Th1 T cells and is dependent on the presence of IFN-gamma for its initial development. As CD4+ T cells from IL-10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::62d0da0accce252aca87c9f07a1573c2
https://pubmed.ncbi.nlm.nih.gov/9759840
https://pubmed.ncbi.nlm.nih.gov/9759840
Autor:
F, Barbut, M, Guiguet, F, Reynaud, J L, Meynard, M M, Fort, M, Chandon, F, Isnard, J, Fronttier, G, Offenstadt
Publikováno v:
Presse medicale (Paris, France : 1983). 26(14)
All the central venous catheters (CVC) inserted at the Saint-Antoine Hospital between December 5, 1994 and June 6, 1995 were prospectively studied in order to better define practices in the management of CVC and to determine the rate of catheter-rela
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2dbc51bfb1551c866e0b26dbe7fe1de0
https://pubmed.ncbi.nlm.nih.gov/9180880
https://pubmed.ncbi.nlm.nih.gov/9180880
Autor:
Hernandez-Green N; Morehouse School of Medicine, Center for Maternal Health Equity, Atlanta, GA, USA., Haiman M; Morehouse School of Medicine, Center for Maternal Health Equity, Atlanta, GA, USA.; University of Texas at Austin, Steve Hicks School of Social Work, Austin, TX, USA., McDonald A; Morehouse School of Medicine, Center for Maternal Health Equity, Atlanta, GA, USA., Rollins L; Morehouse School of Medicine, Department of Community Health and Preventive Medicine, Atlanta, GA, USA.; National African American Child & Family Research Center, Atlanta, GA, USA., Franklin CG; Morehouse School of Medicine, Department of Obstetrics and Gynecology, Atlanta, GA, USA., Farinu OTO; Morehouse School of Medicine, Center for Maternal Health Equity, Atlanta, GA, USA., Clarke L; Morehouse School of Medicine, Center for Maternal Health Equity, Atlanta, GA, USA., Huebshmann A; University of Colorado Anschutz Medical Campus, School of Medicine, Department of Medicine, Division of General Internal Medicine Aurora, CO, USA.; University of Colorado Anschutz Medical Campus, School of Medicine, Ludeman Family Center for Women's Health Research, Aurora, CO, USA.; University of Colorado Anschutz Medical Campus, School of Medicine, Adult & Child Center for Outcomes Research & Delivery Science, Aurora, CO, USA., Fort M; Colorado School of Public Health, Department of Health Systems, Management & Policy, Aurora, CO, USA., Chandler R; Emory University, Nell Hodgson Woodruff School of Nursing, Atlanta, GA, USA., Brocke P; Morehouse School of Medicine, Atlanta, GA, USA., McLaurin-Glass D; Center for Family and Community Wellness, Alpharetta, GA, USA., Harris E; Morehouse School of Medicine, Center for Maternal Health Equity, Atlanta, GA, USA., Berry K; Morehouse School of Medicine, Center for Maternal Health Equity, Atlanta, GA, USA., Suarez A; Morehouse School of Medicine, Center for Maternal Health Equity, Atlanta, GA, USA., Williams T; Morehouse School of Medicine, Center for Maternal Health Equity, Atlanta, GA, USA.
Publikováno v:
MedRxiv : the preprint server for health sciences [medRxiv] 2024 Apr 22. Date of Electronic Publication: 2024 Apr 22.
Autor:
Molinier R; Department of General and Oncologic Dermatology, Ambroise-Paré hospital, AP-HP, Boulogne-Billancourt, France., Roger A; Department of General and Oncologic Dermatology, Ambroise-Paré hospital, AP-HP, Boulogne-Billancourt, France.; Research unit EA4340 'Biomarkers and clinical trials in oncology and onco-hematology', Versailles-Saint-Quentin-en-Yvelines University, Paris-Saclay University, Versailles, France., Genet B; Department of Statistics and Methodology on Biomedical Research, Kremlin-Bicêtre University, Paris-Saclay University, Le Kremlin-Bicêtre, France., Blom A; Department of General and Oncologic Dermatology, Ambroise-Paré hospital, AP-HP, Boulogne-Billancourt, France.; Research unit EA4340 'Biomarkers and clinical trials in oncology and onco-hematology', Versailles-Saint-Quentin-en-Yvelines University, Paris-Saclay University, Versailles, France., Longvert C; Department of General and Oncologic Dermatology, Ambroise-Paré hospital, AP-HP, Boulogne-Billancourt, France.; Research unit EA4340 'Biomarkers and clinical trials in oncology and onco-hematology', Versailles-Saint-Quentin-en-Yvelines University, Paris-Saclay University, Versailles, France., Chaplain L; Department of General and Oncologic Dermatology, Ambroise-Paré hospital, AP-HP, Boulogne-Billancourt, France., Fort M; Department of General and Oncologic Dermatology, Ambroise-Paré hospital, AP-HP, Boulogne-Billancourt, France., Saiag P; Department of General and Oncologic Dermatology, Ambroise-Paré hospital, AP-HP, Boulogne-Billancourt, France.; Research unit EA4340 'Biomarkers and clinical trials in oncology and onco-hematology', Versailles-Saint-Quentin-en-Yvelines University, Paris-Saclay University, Versailles, France., Funck-Brentano E; Department of General and Oncologic Dermatology, Ambroise-Paré hospital, AP-HP, Boulogne-Billancourt, France.; Research unit EA4340 'Biomarkers and clinical trials in oncology and onco-hematology', Versailles-Saint-Quentin-en-Yvelines University, Paris-Saclay University, Versailles, France.
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2022 Mar; Vol. 36 (3), pp. e164-e166. Date of Electronic Publication: 2021 Nov 23.
Autor:
Rettman P; Research Department EA4271, Université, EFS Nantes, Nantes, France., Malard F; HLA Department, EFS Nantes, Nantes, France.; Hematology Department, CHU Hotel Dieu Nantes, Nantes, France., Legrand N; Research Department EA4271, Université, EFS Nantes, Nantes, France., Avinens O; Immunology Department, CHU Montpellier, Montpellier, France., Eliaou JF; Immunology Department, CHU Montpellier, Montpellier, France.; Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI), Paris, France., Picard C; HLA Department, UMR 7268, Université Aix-Marseille, EFS Marseille, Marseille, France., Dormoy A; HLA Department, EFS Besançon, Besançon, France., Lafarge X; HLA Department, EFS Bordeaux, Bordeaux, France., de Matteis M; HLA Department, CHU Nice, Nice, France., Kennel A; HLA laboratory, CHU Nancy, Nancy, France., Loiseau P; HLA Department, Inserm UMR940, AP-HP Paris Saint Louis, Paris, France.; Labex Transplantex, Université Strasbourg, Strasbourg, France., Devys A; HLA Department, EFS Nantes, Nantes, France.; HLA Department, EFS Angers, Angers, France., Boudifa A; HLA Department, AP-HP Paris Saint-Antoine, Paris, France., Absi L; HLA Department, EFS Saint-Etienne, Saint-Etienne, France., Fort M; HLA Department, CHU Toulouse, Toulouse, France., Masson D; HLA Department, EFS Grenoble, Grenoble, France., Quainon F; HLA Department, EFS Clermont-Ferrand, Clermont-Ferrand, France., Theodorou I; Immunology Department, Pitié Salpêtrière Charles Foix, Paris, France., Batho A; HLA Department, EFS Caen, Caen, France., Parissiadis A; HLA Department, EFS Strasbourg, Strasbourg, France., Delbos F; HLA Department, EFS Créteil, Paris, France., Drouet M; HLA Department, CHU Limoges, Limoges, France., Senitzer D; Division of Hematology and Bone Marrow Transplantation, City of Hope, National Medical Center, Duarte, CA, USA., Marry E; Registre France Greffe de Moelle (RFGM), Saint-Denis La Plaine, France., Raus N; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC), Paris, France., Yakoub-Agha I; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC), Paris, France., Cesbron A; HLA Department, EFS Nantes, Nantes, France.; Labex Transplantex, Université Strasbourg, Strasbourg, France., Retière C; Research Department EA4271, Université, EFS Nantes, Nantes, France., Gagne K; Research Department EA4271, Université, EFS Nantes, Nantes, France.; HLA Department, EFS Nantes, Nantes, France.; Labex Transplantex, Université Strasbourg, Strasbourg, France.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2016 Nov; Vol. 51 (11), pp. 1499-1503. Date of Electronic Publication: 2016 Jun 06.
Autor:
Cluzeau T; Service d'hématologie adulte, Hôpital Saint-Louis, APHP, Paris, France.; Centre Méditerranéen de Médecine Moléculaire, INSERM U1065, Nice, France., Lambert J; Hôpital Saint-Louis, Service de Biostatistique et Information Médicale, APHP, Paris, France., Raus N; Data Management of SFGM-TC, Centre Hospitalier Lyon Sud, Pierre-Bénite, France., Dessaux K; Hôpital Saint-Louis, Service de Biostatistique et Information Médicale, APHP, Paris, France., Absi L; Laboratory of Histocompatibility, EFS Saint Etienne, Saint Etienne, France., Delbos F; Laboratory of Histocompatibility, EFS Henri Mondor, Créteil, France., Devys A; Laboratory of Histocompatibility, EFS Pays de la Loire, Nantes, France., De Matteis M; Laboratory of Immunology, CHU Nice, Nice, France., Dubois V; Laboratory of Histocompatibility, EFS Rhone Alpes, Lyon, France., Filloux M; Laboratory of Immunology, CHU Limoges, France., Fort M; Laboratory of Immunology, CHU Toulouse, Toulouse, France., Hau F; Laboratory of Histocompatibility, EFS Normandie, Rouen, France., Jollet I; Laboratory of Histocompatibility, EFS CA, Poitiers, France., Labalette M; Laboratory of Immunology, CHU Lille, Lille, France., Masson D; Laboratory of Histocompatibility, EFS Rhône Alpes, Grenoble, France., Mercier B; Laboratory of Histocompatibility, CHU Brest, France., Pedron B; Laboratory of Immunology, Hôpital Robert Debré, APHP, Paris, France., Perrier P; Laboratory of Histocompatibility, CHU Nancy, Nancy, France., Picard C; Laboratory of Histocompatibility, EFS Alpes Mediterrannée, Marseille, France., Quainon F; Laboratory of Histocompatibility, EFS Clermont-Ferrand, Clermont-Ferrand, France., Ramounau-Pigot A; Laboratory of Immunology, Hôpital Saint-Eloi, Montpellier, France., Renac V; Laboratory of Histocompatibility, EFS Rennes, France., Van Endert P; Laboratory of Immunology, CHU Necker-Enfants Malades, Paris, France., Charron D; Laboratory of Immunology and Histocompatibility, Hôpital Saint-Louis, APHP, Labex Transplantex, Paris, France., Peffault de la Tour R; Service d'hématologie greffe, Hôpital Saint-Louis, APHP, Paris, France., Taupin JL; Laboratory of Immunology and Immunogenetics, CNRS UMR 5164, CHU Bordeaux, France., Loiseau P; Laboratory of Immunology and Histocompatibility, Hôpital Saint-Louis, APHP, Labex Transplantex, Paris, France.; INSERM U1160, Hôpital Saint-Louis, Paris, France.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2016 May; Vol. 51 (5), pp. 687-91. Date of Electronic Publication: 2016 Feb 08.
Autor:
Fort Gasia M; Division of Gastroenterology, University of Calgary, Alberta, Canada - miacucci@ucalgary.ca., Ghosh S, Iacucci M
Publikováno v:
Minerva gastroenterologica e dietologica [Minerva Gastroenterol Dietol] 2015 Dec; Vol. 61 (4), pp. 215-22. Date of Electronic Publication: 2015 Oct 07.